# Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)

> **NCT02080650** · NA · COMPLETED · sponsor: **Duke University** · enrollment: 62 (actual)

## Conditions studied

- Prostate Cancer
- Renal Cell Carcinoma
- Bladder Cancer
- Colorectal Cancer
- Gastric Cancer
- Pancreatic Cancer
- Non-small Cell Lung Cancer
- Advanced MET Amplified Solid Tumor

## Interventions

- **DEVICE:** Mesenchymal-marker based ferrofluid (c-MET)
- **DEVICE:** Epithelial cell adhesion molecule (EpCAM) ferrofluid

## Key facts

- **NCT ID:** NCT02080650
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2016-05-19
- **Final completion:** 2016-07-19
- **Target enrollment:** 62 (ACTUAL)
- **Last updated:** 2017-08-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02080650

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02080650, "Characterization of Circulating Tumor Cells Captured by c-MET (CTC-MET)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02080650. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*